ROCKVILLE, Md. & EDMONTON, Alberta-- ( BUSINESS WIRE )--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Japanese Ministry of Health, Labour, and Welfare ...
AIH: Autoimmune hepatitis; MMF: Mycophenolate mofetil; NA: Not available ... patients to prevent allograft rejection. MMF at a dose of 0.5–2 g daily has been effective at inducing a partial ...
It is the only clinical program to include three years of LN treatment and follow-up with mycophenolate mofetil (MMF ... prolongs the QTc interval in a dose-dependent manner when dosed higher ...
Azathioprine, cyclosporine, mizolibine, mycophenolate mofetil and cyclophosphamide have ... When the disease improves, steroid dosage should be tapered prior to that of the immunosuppressant.
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis ...
The addition of belimumab to standard of care lupus nephritis induction therapy appears effective in real-world patients.
Lupkynis has been approved in Japan to treat lupus nephritis, when given alongside the immunosuppressant mycophenolate ...
Health on MSN9d
Uses and Side Effects of Proton Pump Inhibitors (PPIs)PPIs help treat certain acid-related conditions, such as acid reflux and stomach ulcers. While most PPIs come in oral forms, ...
Report with the AI impact on market trends- The global ursodeoxycholic acid market size is estimated to grow by USD 463.2 million from 2024-2028, according to Technavio. The market is estimated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback